Table 5.
Characteristics | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
|
|
|||||
OR | 95% CI | P | OR | 95% CI | P | |
Age (year) | ||||||
<32 | 1 (references) | - | ||||
≥32 | 0.970 | 0.228-4.151 | 0.970 | |||
Histologic grade | ||||||
I | 1 (references) | - | 1 (references) | - | ||
II | 7.429 | 1.121-49.244 | 0.038 | 4.446 | 0.405-48.785 | 0.222 |
BMI (kg/m2) | ||||||
<27.5 | 1 (references) | - | ||||
≥27.5 | 1.600 | 0.393-6.509 | 0.511 | |||
PCOS | ||||||
No | 1 (references) | - | ||||
Yes | 0.962 | 0.237-3.899 | 0.956 | |||
Metformin | ||||||
No | 1 (references) | - | ||||
Yes | 1.852 | 0.265-12.947 | 0.535 | |||
DM | ||||||
No | 1 (references) | - | ||||
Yes | 1.852 | 0.265-12.947 | 0.535 | |||
HTN | ||||||
No | 1 (references) | - | ||||
Yes | 2.700 | 0.154-47.392 | 0.497 | |||
EM thickness before treatment (mm) | ||||||
<15 | 1 (references) | - | ||||
≥1 | 1.429 | 0.326-6.257 | 0.636 | |||
EM thickness after treatment (mm) | ||||||
<7 | 1 (references) | - | ||||
≥7 | 8.000 | 1.650-38.790 | 0.010 | |||
EM ratio (after treatment/before treatment) | ||||||
<0.55 | 1 (references) | - | 1 (references) | - | ||
≥0.55 | 10.500 | 2.075-53.142 | 0.004 | 19.018 | 1.854-195.078 | 0.013 |
Treatment | ||||||
Oral progestin+LNG-IUD | 1 (references) | - | 1 (references) | −1.356-134.069 | 0.026 | |
Oral progestin | 8.000 | 1.650-38.790 | 0.010 | 13.483 |
Bold numbers indicate P<0.05. OR=Odds ratio; CI=Confidence interval; BMI=Body mass index; PCOS=Polycystic ovary syndrome; DM=Diabetes mellitus; HTN=Hypertension; EM=Endometrium; LNG-IUD=Levonorgestrel-intrauterine device